MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
HRYZ Biotech Co.
HRYZ Biotech Co.
Masonic Cancer Center, University of Minnesota
Montefiore Medical Center
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Dana-Farber Cancer Institute
UNICANCER
National Cancer Institute (NCI)
Swiss Cancer Institute